Research Projects

  • NHMRC Strategic Award, 2009-10 $127,250: Identification of determinants associated with pathogenicity of Swine
  • NHMRC Strategic Award, 2009-10 $64,164: The structure and receptor of the 2009 swine influenza pandemic virus hemagglutinin
  • ACH2, 2009 $66,000: Development of recombinant influenza-SIV vaccines
  • NHMRC Project Grant, 2009-11 $326,584: Dissecting the contribution of malaria translocon components to pathogenesis
  • Future Fellowship, 2010-4 $813,192: Ins and outs of HIV biology 
NHMRC Career Development Award, 2011-4 $424,920: Protein export in malaria parasites
  • Poultry CRC, 2011 $20,186: The role of host factors in viral pathogenesis 
NHMRC Project Grant, 2011 $93,154: Macrophages drive HIV diversity
  • ARC LIEF Grant, 2012 $520,000: Collaborative High Bio-Containment Immunological Research
  • NHMRC Project Grant, 2012-4 $647,350: Improving the management of an emerging viral disease in Australia: determination of the mechanisms  of neuro-invasion by Hendra virus and their control
  • NHMRC Project Grant, 2012-4 $537,350: Functional characterization of the malaria protein
  • NHMRC Project Grant, 2012-4 $475,807: How does host cell influence HIV diversification?
  • NHMRC Project Grant, 2012-4 $584,682: Characterization of the post-entry events of HIV infection
  • 2008-2013 NHMRC Project Grant 509304: $908,750 CI: Bennett CM, Johnson P, Coombs G, Wood G. The epidemiology of Staphylococcus aureus and antibiotic resistance in community-acquired infections
  • 2013 CSIRO Biosecurity Flagship Collaboration Fund Investigator: John Stambas (CIA) Subject of application: Development of Apocynin as a new antiviral for emerging infectious diseases. Amount received: $85,000
  • 2012-2015 NHMRC Hendra Virus Urgent Call for Research (09/2012-09/2015) Application Number: APP1042546 Investigators: John Stambas (CIA), Paul Hertzog (CIB), Carola Vinuesa (CIC), Deborah Middleton (CID), Linfa Wang (CIE). Subject of application: Understanding pathogenicity and immunity in an encephalitic mouse model of Hendra virus infection. Amount received: $562,350
  • 2011-2013 NHMRC Project Grant (2011-2013).Application Number: APP1011027. Administering institution: University, of Sydney, NSW. Investigators: Warwick Britton (CIA), James Triccas (CIB), Manuela Florido (CIC) and John Stambas (CID).Subject of application: Impact of Influenza A infection on T cell-mediated immunity to pulmonary tuberculosis. Amount received: $471,299 ($25,000 to Deakin)
  • 2010-2012 NHMRC Project Grant (2010-2012).Application Number: APP628331.Administering institution: The University of Melbourne. Investigators: Stephen Kent (CIA), John Stambas (CIB),Matthew Law (AI) Miles Davenport (AI) and Gary Nabel (AI). Subject of application: Comparative effectiveness of vaccine-induced SIV-specific CD8+ T cells. Amount received: $588,750 ($180,000 to Deakin)
  • 2011-2014 NIAID CONTRACT NO. HHSN266200700010C Klaassen: Surveillance of influenza A Viruses in wild birds in Australia. $444,000
  • 2013-2015 ARC Discovery DP130101935 Klaassen: Avian migrants as vectors of zoonotic diseases in a changing world. $490,000
  • 2010-2013 Netherlands Science Foundation 820.01.018 Klaassen: Host-pathogen interaction: the effects of avian influenza viruses on free-living Mallards. $ 355,000 (Based in the Netherlands)
  • (AAHL) R-00869-02 Intervention strategies for HeV
  • (AAHL) R-01603-03 Developing an assay to distinguish between HeV infected and HeV vaccinated horses
  • (AAHL) R-02389-01Development of miRNA detection as early diagnosis for HeV infection
  • (AAHL) R-02389-02 Development of miRNA detection as early diagnosis for HeV infection – ferret model
  • (AAHL) R-02196-01 Development of a HeV vaccine for horses
  • (AAHL) R-01788-01 The role of innate immune response in asymptomatic bats
  • (AAHL) R-04408-01 Predicting periods of increased HeV transmission risk through identification of viral co-infections and bio-markers in urine
  • (AAHL) R-02637-01 Understanding the host pathogen relationships of Hendra Virus in Bats, Horses and Humans
  • (AAHL) R-03273-01 Animal trials for NHMRC HeV mouse model project – Stambas – Deakin
  • (AAHL) R-02192-01 RIRDC Flying Fox Hendra Monitoring
  • (AAHL) R-03490-01 Development of reagents to measure immune responses of EIDs in ferret animal model – CMS
  • (AAHL) R-03802-01 Development of enhanced vaccine eggs for reliable supply of flu vaccines – pandemic preparedness (UGA)
  • (AAHL) R-03486-01 New techology for detection of HeV – platform for other EIDs – CMSE
  • (AAHL) R-00869-01 Screening of host genes to identify drug targets as antivirals for HeV
  • (AAHL) R-03489-01 Development of delivery systems for antivirals to combat EIDs – CMSE
  • R-02487-01 Development of a mouse model for studying neuropathology of HeV infection
  • (Barwon Health) Under Mycobacteria ulcerans
    • Ecology GIS study $20,000 Dr I Jeanne
    • Epidemiology Serosurvey $50,000 collaboration Uni Melb, AAHL, Deakin.
    • Transmission studies, Immunopathology Geelong Community Foundation funding $34,000 until mid 2015
    • Clinical trial of maggot debridement therapy with Plastics team $8,000 Community funded
  •   (Barwon Health) Under Clostridium difficile
    • Epidemiology study
    • Novel targets for therapy PhD C Roder, Supervisor M Thomson. (Deakin SRC funded)
  • (Barwon Health)Under Biofilm device infections
    • Orthopedic for VIIN Biotech Industry grant application 2013 in vivo model. ($20,000) also for CRGS internal Deakin ($10,000)
    • Cardiac device registry in collaboration Monash University $500,000 Commonwealth Grant
  • (Barwon Health) Under Clinical trials novel therapies, vaccines and antimicrobial resistance
    • RCT septic arthritis funding DoH $80,000 2013-15
    • RCT cellulitis funding DoH $60,000 2013-15
    • RCT MRGN BSI $200,000 ASA, ISC. NHMRC pending, Univ QLD.
    • Cost effectiveness study $50,000 DoH2013-15
    • Zoster vaccine GSK $300,000 50 subjects 2012-14
    • Ross river vaccine Baxter $150,000 20 subjects 2012-14
    • Refugee Health Hub $2 million from NBN in collaboration with Uni Melb
  • (Barwon Health) Under Endocarditis/ Staphylococcus blood stream infections(Barwon Health) Hand hygiene initiative across BH $500,000
    • Collaboration Duke University NIH grant 2 million
    • ALG $50 million future projects
  • (Barwon Health) Hand hygiene initiative across BH $500,000
  • (Barwon Health) Helicobacter pylori infections and Iron deficiency (M. Thomson, Deakin)